L1000 connectivity map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies. (2020)
Attributed to:
Optimising Innate Host Defence to Combat Antimicrobial Resistance
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.csbj.2020.11.054
PubMed Identifier: 33312454
Publication URI: http://europepmc.org/abstract/MED/33312454
Type: Journal Article/Review
Volume: 18
Parent Publication: Computational and structural biotechnology journal
ISSN: 2001-0370